Neuland Laboratories (NEULANDLAB) Share Price falls 2.04% today
- September 28, 2026
- Posted by: Harsh Piplani
- Category: News
Neuland Laboratories Share Price fell to Rs 21,456.90 today, down 2.04% from the previous close, while the company’s market capitalisation stood at Rs 28,102.52 crore. The move places Neuland Laboratories in focus for Neuland Laboratories Share Price Today and Neuland Laboratories Stock News searches because the session was clearly weaker than the prior close, even though the supplied data does not establish a company-specific catalyst. On the facts available, today’s decline should be read as a price event first and a story second. Univest is covering the move with a factual lens so readers can track the stock without guessing at reasons that are not verified.
At the same time, the company remains a large-cap name in the Healthcare sector and Pharmaceuticals & Drugs industry. For investors scanning Neuland Laboratories Share Price movements, the key question is not only what changed today, but how the current valuation, profitability and peer positioning frame the stock after the fall.
Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 21,456.9 |
| Previous Close | Rs 21,903.95 |
| Today's Move | -Rs 447.05 (-2.04%) |
| Open | Rs 21,763.65 |
| High | Rs 21,844.6 |
| Low | Rs 21,423.7 |
| Turnover | Rs 3.09 crore |
| Market Capitalisation | Rs 28,102.52 crore |
| Market Cap Category | Large Cap |
Neuland Laboratories Share Price Today shows a decline of Rs 447.05, or 2.04%, with the stock closing at Rs 21,456.90 versus the previous close of Rs 21,903.95. The session opened at Rs 21,763.65, touched a high of Rs 21,844.6 and a low of Rs 21,423.7. That range shows the day stayed within a relatively tight band around the lower end of the opening move, but the visible fact remains simple: the share price fell on the day and finished below the previous close.
The turnover was Rs 3.09 crore. The company’s market-cap category is Large Cap, and its market capitalisation was Rs 28,102.52 crore. Those facts make the move relevant for readers following Neuland Laboratories Share Price News,Neuland Laboratories Share Price Update and broader Neuland Laboratories Stock Performance coverage. Since the workflow confirms a same-day price fall but does not establish a company-specific catalyst, the proper interpretation is to focus on the verified session data and the wider financial context. For investors tracking Neuland Laboratories Share Price Live, the next useful step is to compare the fall with the company’s fundamentals and its sector benchmark.
Neuland Laboratories (NEULANDLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 28,102.52 crore |
| P/E Ratio | 56.46x |
| P/B Ratio | 13.9x |
| ROE | 21.43% |
| ROCE | 27.5% |
| EPS | Rs 387.98 |
| Book Value Per Share | Rs 1,575.41 |
| Dividend Yield | 0.16% |
Neuland Laboratories’ fundamental profile shows a market capitalisation of Rs 28,102.52 crore, which positions it well above the sector median in the supplied peer universe. The stock trades at a P/E ratio of 56.46 and a P/B ratio of 13.9, both of which need to be viewed against the Healthcare and Pharmaceuticals & Drugs benchmark rather than in isolation. Its ROE is 21.43% and ROCE is 27.5%, indicating that the business is generating returns above the benchmark medians supplied in the same industry set.
The EPS is Rs 387.98, which shows earnings attributable to each share. Book value is Rs 1,575.41 per share, which gives a simple accounting reference for the equity base behind each share. The dividend yield is 0.16%, a factual payout measure relative to the current share price. For readers searching Neuland Laboratories Fundamental Analysis or Neuland Laboratories Financial Results, these numbers show a company priced at a premium to the broader industry medians, while still supported by strong returns on equity and capital employed. Univest places these figures in context so that the Neuland Laboratories Share Price move is read alongside earnings quality rather than in isolation.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 56.46x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 49.63x |
| Benchmark P/E Range | 3.46x to 735.85x |
| Company P/B Ratio | 13.9x |
| Benchmark Median P/B | 2.85x |
| Benchmark Average P/B | 4.33x |
| Company ROE | 21.43% |
| Benchmark Median ROE | 11.48% |
| Benchmark Average ROE | 10.04% |
| Company ROCE | 27.5% |
| Benchmark Median ROCE | 13.17% |
| Benchmark Average ROCE | 12.82% |
| Company Market Capitalisation | Rs 28,102.52 crore |
| Benchmark Median Market Cap | Rs 732.57 crore |
| Benchmark Average Market Cap | Rs 14,043.26 crore |
The supplied benchmark is the same industry: Pharmaceuticals & Drugs within Healthcare, covering 204 companies. Against that universe, Neuland Laboratories’ P/E of 56.46 is above the sector median of 32.87 and above the sector average of 49.63. Its P/B of 13.9 is also well above the sector median of 2.85 and above the sector average of 4.33. On profitability, its ROE of 21.43% sits above the sector median of 11.48% and the sector average of 10.04%, while its ROCE of 27.5% is above the sector median of 13.17% and the sector average of 12.82%.
The market-cap benchmark also matters: the sector median market capitalisation is Rs 732.57 crore, and the sector average is Rs 14,043.26 crore. Neuland Laboratories’ market capitalisation of Rs 28,102.52 crore is above both. This sector context is important for Neuland Laboratories Stock Analysis because it shows the company is valued richly relative to the broader industry set, while also producing stronger return ratios than the benchmark norms. Univest uses this comparison to separate price movement from valuation context, which is essential when evaluating Neuland Laboratories Stock News and Neuland Laboratories Share News.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,44,716.74 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,55,115.31 | 87.22 | 14.44 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,613.38 | 86.94 | 21.13 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,899.96 | 26.57 | 4.45 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,875.68 | 33.49 | 3.21 | 11.83 | 16 |
Within the supplied peer set, Neuland Laboratories sits above several listed pharmaceutical names on returns, but its valuation is also higher than most peers shown. Sun Pharmaceutical Industries has a P/E of 36.77 and market cap of Rs 4,44,716.74 crore, while Zydus Lifesciences has a P/E of 26.57 and market cap of Rs 1,19,899.96 crore. Cipla is at a P/E of 33.49, and Dr. Reddy’s Laboratories is at 31.16.
On profitability, Neuland Laboratories’ ROE of 21.43% is above Sun Pharma, Zydus Lifesciences, Cipla and Dr. Reddy’s in the peer list shown, though it is below Torrent Pharmaceuticals at 26.76% and Lupin at 27.11%. Its ROCE of 27.5% is also stronger than most peers in the sample. For Neuland Laboratories Share Price readers, the takeaway is factual: the stock is not the cheapest in the group, but its return ratios stand out versus several comparables.
Why Investors Are Watching Neuland Laboratories
- Neuland Laboratories Share Price fell 2.04% today to Rs 21,456.90, below the previous close of Rs 21,903.95.
- The day’s open was Rs 21,763.65, the high was Rs 21,844.6 and the low was Rs 21,423.7.
- Market capitalisation stood at Rs 28,102.52 crore and the company is classified as Large Cap.
- P/E was 56.46, P/B was 13.9, ROE was 21.43% and ROCE was 27.5%.
- In the industry benchmark, the company’s P/E, P/B, ROE and ROCE all sit above the median figures supplied.
About Neuland Laboratories
Neuland Laboratories operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company through its listed market profile and benchmark universe, which places it among 204 same-industry companies. For readers following Neuland Laboratories Company News or Neuland Laboratories Latest News, the most useful factual frame is its combination of large-cap size, premium valuation and above-benchmark profitability metrics. Univest presents the stock within this exact sector and industry context so the Neuland Laboratories Share Price event can be interpreted against verifiable financial data.
Track Neuland Laboratories Share Price on Univest
Use Neuland Laboratories (NEULANDLAB) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Univest helps you track Neuland Laboratories Share Price, current market cap, valuation ratios, return metrics, shareholding pattern and sector comparison in one place. You can also review live stock updates, 52-week levels and market insights for a fuller view of the company’s listed performance.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Neuland Laboratories Share Price fall today?
Ans. The supplied data confirms a 2.04% decline in Neuland Laboratories Share Price today, but it does not establish a company-specific catalyst. The stock closed at Rs 21,456.90 versus Rs 21,903.95 previously.
What is Neuland Laboratories Share Price today?
Ans. Neuland Laboratories Share Price today is Rs 21,456.90. The stock moved down by Rs 447.05, or 2.04%, from the previous close, making the day’s session a clear decline in the market.
What is the market capitalisation of Neuland Laboratories?
Ans. Neuland Laboratories has a market capitalisation of Rs 28,102.52 crore. The company is classified as Large Cap in the supplied data, which is useful context when reading the day’s share price movement.
How does Neuland Laboratories compare with its industry peers?
Ans. Neuland Laboratories’ valuation is above the industry median, while its ROE and ROCE are also above the benchmark figures supplied. That combination places the stock in a distinct position within the Pharmaceuticals & Drugs peer set.
What do Neuland Laboratories’ valuation ratios show?
Ans. The company’s P/E is 56.46 and P/B is 13.9. Those values are higher than the sector median figures supplied, so the stock is valued at a premium relative to the broader industry benchmark.
What do EPS and book value say about Neuland Laboratories?
Ans. EPS is Rs 387.98 and book value is Rs 1,575.41 per share. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
Is Neuland Laboratories part of the Healthcare sector?
Ans. Yes. Neuland Laboratories belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. This classification is important because the article compares the stock with same-industry companies and benchmark figures.
What should investors monitor next in Neuland Laboratories Share Price?
Ans. Investors can monitor whether the share price continues to trade around the day’s low of Rs 21,423.7 or recovers toward the opening price of Rs 21,763.65. Valuation and sector comparison remain important context.
